title: Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?
authors.forename: Firouzé
authors.initials: F
authors.lastname: Bani-Sadr
authors.forename: Pierre
authors.initials: P
authors.lastname: Bedossa
authors.forename: Eric
authors.initials: E
authors.lastname: Rosenthal
authors.forename: Dominique
authors.initials: D
authors.lastname: Merrien
authors.forename: Philippe
authors.initials: P
authors.lastname: Perre
authors.forename: Caroline
authors.initials: C
authors.lastname: Lascoux-Combe
authors.forename: Patrice
authors.initials: P
authors.lastname: Cacoub
authors.forename: Christian
authors.initials: C
authors.lastname: Perronne
authors.forename: Stanislas
authors.initials: S
authors.lastname: Pol
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects; D016174:Hepacivirus / Q000187:drug effects; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged